Bruntwood has today announced the purchase of AstraZeneca’s 400-acre global research and development site Alderley Park in Cheshire.
The commercial property company is buying the Cheshire site with its subsidiary Manchester Science Parks and Cheshire East Council, furthering its
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.
